Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guerin Immunotherapy

Erstveröffentlichung

2022

Authors

Mayr, Roman

Eckstein, Markus

Wirtz, Ralph M.

Santiago-Walker, Ademi

Baig, Mahadi

et al.

Wissenschaftlicher Artikel

Published in

European Urology ; 81 (2022), 6. - S. 606-614. - ISSN 0302-2838. - eISSN 1873-7560

Link to publication

https://dx.doi.org/10.1016/j.eururo.2022.02.028

Institutions

UKU. Klinik für Urologie und Kinderurologie

Subject headings

[Free subject headings]: Bacillus Calmette-Gu?rin | Bladder cancer | Fibroblast growth factor receptor | FGFR alterations | Non-muscle-invasive bladder | cancer | FGFR3 MUTATIONS | UROTHELIAL CARCINOMA | GUIDELINES | BCG | PEMBROLIZUMAB | ASSOCIATION | PROGRESSION | RECURRENCE | BIOMARKER | NMIBC
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record